Cited by 59Lung Cancer Diagnosis and TreatmentMultiple and Secondary Primary CancersAdvanced Radiotherapy Techniques

Treatment of multiple primary lung cancers using stereotactic radiotherapy, either with or without surgery

Griffioen, Gwendolyn H.M.J., Lagerwaard, Frank J., Haasbeek, Cornelis J.A., Smit, Egbert F., Slotman, Ben J., Senan, Suresh·2013·Radiotherapy and Oncology

Abstract

Background and purpose Multiple primary lung cancers (MPLC) are not an uncommon presentation. Current guidelines recommend a curative approach when early-stage MPLC is diagnosed as favorable outcomes have been reported after surgery. We studied outcomes following stereotactic ablative radiotherapy (SABR).Materials and methods Following review of imaging and pathology at a multi-disciplinary tumor board, a total of 62 patients were referred for SABR with a diagnosis of synchronous MPLC. SABR was performed for both lesions in 56 patients, while another 6 underwent SABR for only one lesion and surgery for the other lesion. A total dose of 54-60 Gy was delivered in 3-8 fractions.Results Median follow-up was 44 months (95% CI: 29-59). Overall survival of all patients was 31 months (95% CI: 17-44), with an actuarial 2-year survival of 56%. No grade 4 or 5 post-SABR toxicity was observed. Local control rates calculated per lesion, were 84% at 2 years, and 78% at 3 years. The two-year actuarial regional control rate was 87%.Conclusions SABR for synchronous MPLC achieves a lesion control rate of 84% after 2 years, with limited toxicity. SABR should be considered when patients with lung cancer present with a synchronous second lesion and no nodal involvement.

Integrity signals

Registry

Crossref · 10.1016/j.radonc.2013.04.026

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Griffioen, G. H. M. J., Lagerwaard, F. J., Haasbeek, C. J. A., Smit, E. F., Slotman, B. J., & Senan, S.
Affiliations
Amsterdam UMC Location Vrije Universiteit Amsterdam (NL)
Corresponding author
Lagerwaard, Frank J.
Venue
Radiotherapy and Oncology
Publisher
Elsevier BV
Published
2013-06
Volume
107
Issue
3
Pages
403-408
ISSN
0167-8140 (ISSN-L)
OpenAlex
W2047551490
Cited by
59
References
25
Citations by year
2026: 2 · 2025: 2 · 2024: 2 · 2023: 9 · 2022: 5 · 2021: 3 · 2020: 5 · 2019: 5 · 2018: 9 · 2017: 4 · 2016: 4 · 2015: 3 · 2014: 4 · 2013: 2
FWCI
3.53
Type
journal article
Language
en
Open access
closed
Locations
  • Radiotherapy and Oncology (publishedVersion)
  • PubMed (publishedVersion)
  • Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
  • Pure Amsterdam UMC (submittedVersion)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
Topics
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Lung Cancer Diagnosis and Treatment
  • Health Sciences › Medicine › Epidemiology › Multiple and Secondary Primary Cancers
  • Physical Sciences › Physics and Astronomy › Radiation › Advanced Radiotherapy Techniques
Keywords
multiple primary lung cancer, synchronous lung tumors, stereotactic body radiotherapy, lung cancer surgery, local control, overall survival, regional control, treatment toxicity, curative treatment
MeSH terms
Aged, Aged, 80 and over, Female, Humans, Lung Neoplasms, Male, Middle Aged, Neoplasms, Multiple Primary, Radiotherapy Dosage, Tomography, X-Ray Computed, Radiosurgery

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review